CCND1 and diffuse large B-cell lymphoma: Kobayashi et al published another larger study involving 109 de novo CD5+ DLBCL casesprimarily studying their clinical characteristics.19 These cases were compared with 384 CD5− DLBCL and 128 cyclin D1–positive MCLcases.